Complete Funding Blueprint
Recommended hereGet the complete self-serve report, roadmap, and multi-year stacking simulation.
Understand the eligibility guidelines, funding caps, application timelines, and stacking playbooks for both options.

Provides non-dilutive funding to early-stage startups developing highly innovative, high-risk technologies with deep commercial market potential.
View GuideKnown as America's Seed Fund for life sciences, these awards fund early-stage research and development with commercialization potential in biotech, medical devices, and digital health.
View Guide| Dimension | NSF Parameters | NIH Parameters |
|---|---|---|
| University Partnership | SBIR: Optional — small business leads all research independently | STTR: Mandatory — university or research institution must lead 30%+ of work |
| Phase I Award | Up to $275,000 (NSF) or $275,000 (NIH) for 6–12 months | Up to $275,000+ for 12–24 months (both NSF and NIH STTR) |
| Phase II Award | Up to $1,900,000 (NSF) / $1,000,000 (NIH) for 2 years | Up to $1,900,000+ over 2 years (both NSF and NIH STTR) |
| Eligible Entity | US-incorporated small business, majority US-owned, primary research in USA | US small business + formal agreement with US university/research hospital |
| Best Fit | Independent startups with in-house research teams and proprietary IP goals | Startups that need academic GPU clusters, labs, or clinical research access |
How to optimize your filings by leveraging both programs in parallel.
You can apply to both SBIR and STTR programs but not for the same project scope. The typical strategy:
Public funding eligibility varies significantly by sector. Select your industry to view custom program matches and stacking playbooks:
Detailed guides on programs related to this comparison:
Provides non-dilutive funding to early-stage startups developing highly innovative, high-risk technologies with deep commercial market potential.
Known as America's Seed Fund for life sciences, these awards fund early-stage research and development with commercialization potential in biotech, medical devices, and digital health.
Canada's largest tax incentive for businesses conducting scientific research or experimental development. Provides a fully refundable investment tax credit (ITC) for eligible R&D expenditures.
Provides non-repayable grants and advisory support to help Canadian small and medium-sized enterprises (SMEs) develop and commercialize innovative technologies.
Our analysts review business registration records, technical R&D payroll, and market goals to draft custom stacking models.
Calculate potential matching grants and tax credits for your business profile.
Browse city-level funding guides in this sector:
Official Program Alignment
FSI Digital reviews eligibility standards in accordance with official guidelines. We never guarantee funding; all approvals are subject to official government program review.
Recommended self-serve next step
Instant digital delivery. No sales call, live session, or consultation is required.
Get the complete self-serve report, roadmap, and multi-year stacking simulation.